1. 3112 Nintedanib in combination with cisplatin/gemcitabine as 1st-line therapy for advanced squamous non-small cell lung cancer. (September 2015) Authors: Forster, M.; Hackshaw, A.; Pas, T. De; Cobo, M.; Garrido, P.; Summers, Y.; Dingemans, A.M.; Flynn, M.; Von Wangenheim, U.; Temple, G.; Loembé, A.B.; Lee, S.M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis. (April 2019) Authors: de Rouw, N.; Croes, S.; Posthuma, R.; Agterhuis, D.E.; Schoenmaekers, J.J.A.O.; Derijks, H.J; Burger, D.M.; Dingemans, A.M.; ter Heine, R. Journal: Lung cancer Issue: Volume 130(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SP-0687 Combining Radiotherapy with Immunotherapy: focus on immunocytokines. (April 2019) Authors: Lambin, Philippe; Lieverse, R.; Van Limbergen, E.J.; Pimentel, V. Olivo; Marcus, D.; Van Der Wiel, A.; Theys, J.; Yaromina, A.; Dubois, L.J.; Hoeben, A.; Dingemans, A.M. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗